Pharmaceutical Technology Development Co.

China Pharmaceutical Technology Development Co., Ltd. (CPTDC) is a specialized research and development subsidiary of the China National Pharmaceutical Group (Sinopharm). Headquartered in Beijing, the company serves as a critical hub for the industrialization of pharmaceutical technologies and the development of biological products. CPTDC is internationally recognized for its central role in the research, development, and clinical testing of Sinopharm's inactivated COVID-19 vaccines. Beyond vaccines, the company provides comprehensive services in technology transfer, clinical trial management, and pharmaceutical consulting to support the broader Sinopharm ecosystem. As a state-owned enterprise, it bridges the gap between academic research and large-scale commercial manufacturing. The company's work spans multiple therapeutic areas, including infectious diseases, oncology, and immunology.